Controlled Enzymatic Hydrolysis: A New Strategy for the Discovery of Antimicrobial Peptides

Probiotics and Antimicrobial Proteins
Estelle Yaba AdjeNaïma Nedjar-Arroume

Abstract

The use of antimicrobial peptides (AMPs) is an alternative to traditional antibiotics. AMPs are obtained using different methods such as bacterial synthesis, chemical synthesis and controlled enzymatic hydrolysis. The later is an interesting approach that deserves our attention because of the yields gathered and peptides engineered. Usually, activities of AMPs obtained in such a way are tightly dependent on the hydrolysis mechanism used. This paper deals with the hydrolysis of hemoglobin mechanism as a potential source of AMPs. Production of AMPs from hemoglobin using enzymatic controlled system is linked to hemoglobin structure. Further, we show that bovine hemoglobin, which is sensitive to peptic hydrolysis, results upon enzymatic digestion as a great source of AMPs. The hemoglobin in native and denatured states was hydrolyzed by "one-by-one" and "zipper" mechanisms, respectively. Nevertheless, a new mechanism named "semi-zipper" mechanism is obtained when protein is in molten globule structural state, constituting an original strategy for AMPs production. Seventy seven percentage of the peptides obtained by this new strategy showed antibacterial activity against nine strains.

References

Nov 30, 1992·Biochemical and Biophysical Research Communications·J M PiotD Thomas
Dec 1, 1992·Neurochemical Research·N BarkhudaryanA Galoyan
Jan 1, 1995·Advances in Microbial Physiology·R E HancockM Brown
Mar 6, 1998·Trends in Biotechnology·R E Hancock, R Lehrer
Mar 31, 1998·Current Opinion in Structural Biology·V S PandeD S Rokhsar
Aug 28, 1999·The Journal of Biological Chemistry·A C FogaçaS Daffre
Feb 28, 2001·FEBS Letters·R FroidevauxD Guillochon
Mar 16, 2001·Bioorganic & Medicinal Chemistry·C A ParishJ E Gabay
Apr 6, 2002·Journal of Protein Chemistry·José González-Jiménez, Manuel Cortijo
Aug 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Danilo RoccatanoAlan E Mark
Sep 3, 2003·Bioscience, Biotechnology, and Biochemistry·Wakako TsuzukiAkihiko Nagao
Feb 1, 1958·The Journal of Experimental Medicine·D HODSON, J G HIRSCH
Jun 11, 2004·Antonie van Leeuwenhoek·P MakA Dubin
Oct 27, 2004·Peptides·Paweł MakAdam Dubin
Apr 6, 2005·Peptides·Rachid DaoudDidier Guillochon
Oct 18, 2005·Journal of Colloid and Interface Science·Swati De, Agnishwar Girigoswami
Dec 27, 2005·The Journal of Physical Chemistry. B·Helén JanssonJan Swenson
May 30, 2006·Peptides·Naima Nedjar-ArroumeDidier Guillochon
Sep 19, 2006·Journal of the American Society for Mass Spectrometry·Brian L Boys, Lars Konermann
Sep 19, 2006·Journal of Structural Biology·Jane F PoveyMark J Howard
Sep 14, 2007·International Journal of Biological Macromolecules·Nasrollah Rezaei-GhalehMohsen Nemat-Gorgani
Mar 18, 2008·Peptides·Naïma Nedjar-ArroumeDidier Guillochon
Apr 23, 2011·International Journal of Biological Macromolecules·Estelle Yaba AdjeNaïma Nedjar-Arroume

❮ Previous
Next ❯

Citations

Apr 27, 2017·Foods·Eric Banan-Mwine DaliriByong H Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Nature Structural Biology
O B Ptitsyn
Nature Structural Biology
J J EwbankF Ulrich Hartl
Advances in Protein Chemistry
M Arai, K Kuwajima
International Journal of Biological Macromolecules
Estelle Yaba AdjeNaïma Nedjar-Arroume
© 2022 Meta ULC. All rights reserved